K

Kinoxis Therapeutics

Kinoxis Therapeutics is a biotech company developing drugs for agitation and pain associated with dementia. The company is a spinout from Sydney University and is now based in Melbourne. This funding will support clinical trials for their drug candidates, KNX100 and KNX101, with results expected in 2027.

Total raised
Undisclosed
tracked to date
Latest round
Grant
Sep 23, 2026
Known investors
6
led by Main Sequence

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Australia.

Claim this profile →

🏆 Featured in Datapile’s Q3 2026 Australia Funding Report

Read the Q3 2026 Australia report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-australia-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 Australia Funding Report</a>

Funding history

  1. 1
    $6.75 millionGrantSep 23, 2026

    Led by Main Sequence

    Announcement ↗

Investors in Kinoxis Therapeutics

Backers from this company's tracked funding rounds.

  • MMain SequenceLead investorVC firm
  • UUniseedVC firm
  • UUniSuperVC firm
  • SSydney UniVC firm
  • SStoic VCVC firm
  • AAvicella CapitalVC firm

Kinoxis Therapeutics in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile